Aerodynamic Measurements in the Pediatric Population

NCT ID: NCT06975046

Last Updated: 2025-11-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

365 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-31

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to create a vocal health database of people aged 4-17 with no diagnosed voice pathology. The main question it aims to answer is:

* what is the best way to assess pediatric voices; and,
* what are the differences between healthy and dysphonic pediatric voices?

Participants will complete one 60 minute session involving one of three types of aerodynamic interruption.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary goals of this research are to develop noninvasive aerodynamic assessments specific to the pediatric population, and to describe differences between healthy and dysphonic pediatric voices between the ages of 4-17 years. To account for challenges associated with pediatric data collection, we will modify our current devices and methods of aerodynamic assessment to be better suited for use with the pediatric population and aim to increase measurement reliability in younger subjects. Our proposed modifications include shorter trial times, auditory masking, the use of cheek restraints, and gamification.

After identification of optimal data collection conditions for each method, we will compare these in a large group of children with normal voice. These data will be compared to data from children with vocal fold nodules or polyp. All data will be compiled into a pediatric vocal health database

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Normal Voice

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Complete airflow interruption

Group Type EXPERIMENTAL

Complete airflow interruption

Intervention Type DEVICE

Participants will produce a sustained vowel into a mouthpiece (with nose-clip) connected to a PVC tube, with a balloon valve

Incomplete airflow interruption

Group Type EXPERIMENTAL

Incomplete airflow interruption

Intervention Type DEVICE

Incomplete airflow interruption uses a Y-shaped device. The participant produces a sustained /a/ into a mouthpiece and air filter connected to the tube. The tube splits into two tubes distally.

Airflow redirection

Group Type EXPERIMENTAL

Airflow redirection

Intervention Type DEVICE

Participant phonates through a mouthpiece into a PVC tube that splits into two paths. One path is connected to an open balloon valve. When the balloon is inflated and blocks the path, air is redirected into the other path which is gated by a one-way valve.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Complete airflow interruption

Participants will produce a sustained vowel into a mouthpiece (with nose-clip) connected to a PVC tube, with a balloon valve

Intervention Type DEVICE

Incomplete airflow interruption

Incomplete airflow interruption uses a Y-shaped device. The participant produces a sustained /a/ into a mouthpiece and air filter connected to the tube. The tube splits into two tubes distally.

Intervention Type DEVICE

Airflow redirection

Participant phonates through a mouthpiece into a PVC tube that splits into two paths. One path is connected to an open balloon valve. When the balloon is inflated and blocks the path, air is redirected into the other path which is gated by a one-way valve.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 4-17 years
* Normal voice
* No history of voice or other pertinent health disorders


* Age 4-17
* Laryngeal pathology

Exclusion Criteria

* Neuromuscular disorder affecting the larynx
* History of respiratory or laryngeal disease
* History of smoking
* Hearing impairment
* Cognitive impairment that might impact ability to perform the tasks required by the study


* No laryngeal disorder
Minimum Eligible Age

4 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Iowa

OTHER

Sponsor Role collaborator

University of Wisconsin, Madison

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jack Jiang, MD

Role: PRINCIPAL_INVESTIGATOR

University of Wisconsin, Madison

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Iowa

Iowa City, Iowa, United States

Site Status

University of Wisconsin - Madison

Madison, Wisconsin, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jack Jiang, MD

Role: CONTACT

Email: [email protected]

Owen Wischhoff

Role: CONTACT

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Matt Hoffman

Role: primary

Jack Jiang, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

A539770

Identifier Type: OTHER

Identifier Source: secondary_id

SMPH/SURGERY/OTOLARYNGOLOGY

Identifier Type: OTHER

Identifier Source: secondary_id

Protocol Version 11/20/2024

Identifier Type: OTHER

Identifier Source: secondary_id

2024-1776

Identifier Type: -

Identifier Source: org_study_id